MELYSSA WIGGINS: Open Payments
NPI 1245798347 · MC LEANSBORO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$317 in 20 payments from 5 companies in 2025. Trend: 2023 $380 · 2024 $270 · 2025 $317
Food & beverage: $317
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $137 |
| Lilly USA, LLC | 6 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: MOUNJARO, Rybelsus, Kerendia, Ozempic, Auvelity, SPRAVATO.
Industry payments across IL — which companies pay providers there.
